rs6046
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM1BP4_StrongBA1
The NM_019616.4(F7):c.1172G>A(p.Arg391Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.116 in 1,612,500 control chromosomes in the GnomAD database, including 12,920 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_019616.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F7 | ENST00000346342.8 | c.1172G>A | p.Arg391Gln | missense_variant | Exon 8 of 8 | 1 | NM_019616.4 | ENSP00000329546.4 | ||
F7 | ENST00000375581.3 | c.1238G>A | p.Arg413Gln | missense_variant | Exon 9 of 9 | 1 | ENSP00000364731.3 | |||
F7 | ENST00000541084.5 | c.986G>A | p.Arg329Gln | missense_variant | Exon 6 of 6 | 2 | ENSP00000442051.2 |
Frequencies
GnomAD3 genomes AF: 0.116 AC: 17693AN: 152072Hom.: 1172 Cov.: 33
GnomAD3 exomes AF: 0.129 AC: 32014AN: 247448Hom.: 2706 AF XY: 0.138 AC XY: 18602AN XY: 134762
GnomAD4 exome AF: 0.116 AC: 170074AN: 1460312Hom.: 11745 Cov.: 33 AF XY: 0.122 AC XY: 88822AN XY: 726428
GnomAD4 genome AF: 0.116 AC: 17700AN: 152188Hom.: 1175 Cov.: 33 AF XY: 0.116 AC XY: 8666AN XY: 74410
ClinVar
Submissions by phenotype
not specified Pathogenic:1Benign:2
- -
- -
This is a frequently occurring variant found in either the heterozygous or homozygous state in many individuals who are not affected by factor VII (FVII) deficiency. Data from several studies suggest the p.Arg413Gln (aka p.Arg353Gln) substitution is associated with decreased plasma levels of Factor VII (Arbini. 1994. PubMed ID: 7919338; Lane et al. 1996. PubMed ID: 8929253; Ken-Dror et al. 2010. PubMed ID: 20735728). Some reports suggest the p.Arg413Gln variant is associated with increased risk of myocardial infarction / coronary heart disease (Mo et al. 2011. PubMed ID: 21838885), while a recent Meta analysis suggests p.Arg413Gln is NOT associated with myocardial infarction (Huang et al. 2018. PubMed ID: 30278561). Taken together, data suggest the p.Arg413Gln variant is associated with decreased levels of FVII; while it is not directly pathogenic it may contribute to the consequence of co-inherited variants (Giansily-Blaizot et al. 2020. PubMed ID: 32333443) which may include modulating the effect of variants in other genes such as F8 and F9 (Jayandharan et al. 2009. PubMed ID: 19686262). In this context, we consider the p.Arg413Gln substitution a risk allele. -
not provided Benign:2
- -
See Variant Classification Assertion Criteria. -
Factor VII deficiency Benign:1
- -
Factor X deficiency Benign:1
- -
Myocardial infarction, decreased susceptibility to Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at